Vitamin C (ascorbic acid) is one of the most studied nutrients in human biology, with a research record spanning more than a century. Yet despite this familiarity, a fundamental distinction is frequently overlooked: oral vitamin C and intravenous vitamin C are pharmacologically different interventions that produce different plasma concentrations, activate different biological mechanisms, and have different clinical applications. Understanding this distinction is essential to understanding why IV delivery matters.

The Pharmacokinetics of Oral vs. IV Vitamin C

When vitamin C is taken orally, it is absorbed in the small intestine via sodium-dependent vitamin C transporters (SVCT1 and SVCT2). These transporters are saturable — meaning that as the dose increases, the percentage absorbed decreases. At a dose of 200 mg, absorption is approximately 100%. At 1,000 mg, absorption falls to approximately 50%. At doses above 2,000–3,000 mg, absorption may fall below 20%, with the remainder causing gastrointestinal distress and being excreted.[1]

The maximum plasma concentration achievable with oral dosing is tightly regulated at approximately 80–100 μmol/L, regardless of how much is consumed. This ceiling is a physiological safety mechanism — the body tightly controls circulating vitamin C levels through intestinal absorption limits and rapid renal excretion.

Intravenous vitamin C bypasses intestinal absorption entirely. When delivered directly into the bloodstream, plasma concentrations can reach 10,000–20,000 μmol/L — 70 to 100 times higher than the oral ceiling. These pharmacological concentrations are not achievable by any oral route and activate biological mechanisms that are simply not accessible at physiological concentrations.[1][2]

Immune Support: The Evidence Base

Vitamin C is essential for immune function at multiple levels. It accumulates in neutrophils and lymphocytes at concentrations 10–100 times higher than plasma, where it supports the oxidative burst used to kill pathogens, protects immune cells from oxidative self-damage, and stimulates the production and function of T-cells, B-cells, and natural killer cells.[3]

A 2017 review in Nutrients by Carr and Maggini documented vitamin C's role in supporting both innate and adaptive immunity, concluding that "vitamin C deficiency results in impaired immunity and higher susceptibility to infections" and that "supplementation with vitamin C appears to be able to both prevent and treat respiratory and systemic infections."[3]

High-dose IV vitamin C has been studied specifically in the context of sepsis and critical illness, where oxidative stress rapidly depletes vitamin C stores. A 2019 randomized controlled trial published in JAMA found that IV vitamin C combined with thiamine and hydrocortisone significantly reduced 28-day mortality in patients with sepsis, though subsequent larger trials have produced mixed results, highlighting the importance of patient selection and timing.[4]

Collagen Synthesis: The Structural Connection

Vitamin C is an essential cofactor for two enzymes — prolyl hydroxylase and lysyl hydroxylase — that are required for the synthesis of stable collagen. Without adequate vitamin C, collagen molecules cannot be properly cross-linked, producing structurally weak collagen that is prone to degradation. This is the mechanism underlying scurvy, the classic vitamin C deficiency disease characterized by wound healing failure, skin fragility, and joint pain.

At therapeutic concentrations, vitamin C does not merely prevent collagen degradation — it actively stimulates collagen synthesis. Research has shown that vitamin C upregulates the expression of collagen genes and stimulates fibroblast proliferation, the cells responsible for producing new collagen. IV delivery, by achieving plasma concentrations far above the oral ceiling, provides fibroblasts with the substrate needed for maximal collagen production — relevant not only for skin aging but for wound healing, joint health, and connective tissue repair throughout the body.[2]

Cancer Adjunct Research: What the Evidence Actually Shows

The most controversial and most discussed application of high-dose IV vitamin C is as an adjunct to cancer treatment. The mechanism of interest is straightforward: at pharmacological plasma concentrations (above approximately 1,000 μmol/L), vitamin C acts as a pro-oxidant rather than an antioxidant, generating hydrogen peroxide in the extracellular fluid surrounding tumor cells. Cancer cells, which have reduced antioxidant capacity compared to normal cells, are selectively vulnerable to this hydrogen peroxide-mediated oxidative stress.[2]

A 2014 Phase 1 clinical trial published in Science Translational Medicine by Schoenfeld and colleagues demonstrated that high-dose IV vitamin C was safe and well-tolerated in combination with standard chemotherapy (carboplatin and paclitaxel) in patients with ovarian cancer, and showed signals of improved progression-free survival compared to chemotherapy alone.[5] A 2019 Phase 2 trial in glioblastoma patients found that IV vitamin C combined with standard treatment was safe and associated with improved quality of life.[2]

It is important to be precise about what this evidence does and does not show. High-dose IV vitamin C is not a cancer treatment — it is a potential adjunct that may improve outcomes when combined with standard care in specific cancer types. The evidence is promising but not yet definitive, and it should be discussed with an oncologist in the context of an individual patient's treatment plan.

Antioxidant Effects and Recovery Applications

At the concentrations achievable with IV delivery, vitamin C is one of the most potent antioxidants in human physiology. It directly scavenges reactive oxygen species, regenerates other antioxidants (particularly vitamin E and glutathione), and protects cellular membranes from lipid peroxidation. These properties make high-dose IV vitamin C particularly relevant for recovery from intense physical exertion, acute illness, surgery, and any condition characterized by elevated oxidative stress.[3]

At Nectar Wellness, vitamin C is a core component of our Myers' Cocktail and is available as a standalone high-dose infusion for immune support, recovery, and general wellness. Our clinical team will recommend the appropriate dose and protocol based on your individual health goals.

"Intravenous vitamin C achieves plasma concentrations 70–100 times higher than the oral ceiling, activating pro-oxidant mechanisms in tumor cells and antioxidant mechanisms in normal cells that are simply not accessible by any oral route." — Padayatty & Levine, Oral Diseases, 2016